We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNG icon
7176
CALL
Scorpio Tankers
STNG
$3.83B
$12K ﹤0.01%
+300
New +$10.3K
SVT
7177
DELISTED
Servotronics
SVT
$12K ﹤0.01%
1,166
-955
-45% -$9.88K
TATT icon
7178
TAT Technologies
TATT
$518M
$12K ﹤0.01%
2,295
+352
+18% +$1.77K
TGB
7179
Trekor Metals
TGB
$3.01B
$12K ﹤0.01%
+25,117
New +$10.6K
VMD icon
7180
Viemed Healthcare
VMD
$363M
$12K ﹤0.01%
+2,010
New +$13.9K
IRD
7181
Opus Genetics
IRD
$307M
$12K ﹤0.01%
1,585
+176
+12% +$1.33K
FAIL
7182
DELISTED
Cambria Global Tail Risk ETF
FAIL
$12K ﹤0.01%
496
-738
-60% -$18.6K
AUMN
7183
DELISTED
Golden Minerals Company
AUMN
$12K ﹤0.01%
1,568
-1,377
-47% -$8.54K
NM
7184
DELISTED
Navios Maritime Holdings Inc.
NM
$12K ﹤0.01%
2,653
+1,445
+120% +$7.16K
STCN
7185
DELISTED
Steel Connect, Inc. Common Stock
STCN
$12K ﹤0.01%
912
+172
+23% +$2.4K
AGRX
7186
DELISTED
Agile Therapeutics
AGRX
$12K ﹤0.01%
+2
New +$6.99K
CTEK
7187
DELISTED
CynergisTek, Inc.
CTEK
$12K ﹤0.01%
+3,695
New +$11.2K
AMTBB
7188
DELISTED
Amerant Bancorp Inc. Class B Common Stock
AMTBB
$12K ﹤0.01%
743
+48
+7% +$714
RFUN
7189
DELISTED
RiverFront Dynamic Unconstrained Income
RFUN
$12K ﹤0.01%
464
-326
-41% -$8.28K
CCRC
7190
DELISTED
China Customer Relations Centers, Inc
CCRC
$12K ﹤0.01%
1,306
+838
+179% +$8.46K
LACQW
7191
DELISTED
Leisure Acquisition Corp. Warrant
LACQW
$12K ﹤0.01%
12,000
-100
-0.8% -$70
APHA
7192
DELISTED
Aphria Inc. Common Shares
APHA
$12K ﹤0.01%
2,225
-21,666
-91% -$106K
PRCP
7193
DELISTED
Perceptron Inc
PRCP
$12K ﹤0.01%
2,172
+52
+2% +$249
GFIN
7194
DELISTED
Goldman Sachs Finance Reimagined ETF
GFIN
$12K ﹤0.01%
203
+7
+4% +$397
FKO
7195
DELISTED
First Trust South Korea AlphaDEX Fund
FKO
$12K ﹤0.01%
588
-208
-26% -$4.18K
SPAQ.U
7196
DELISTED
Spartan Energy Acquisition Corp Units (each consisting of one Class A Common Stock and one-third of
SPAQ.U
$12K ﹤0.01%
1,200
ACTTU
7197
DELISTED
Act II Global Acquisition Corp Unit
ACTTU
$12K ﹤0.01%
1,100
ZBIO
7198
DELISTED
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
$12K ﹤0.01%
1,346
-2,043
-60% -$24.8K
OMOM
7199
DELISTED
Invesco Russell 1000 Momentum Factor ETF
OMOM
$12K ﹤0.01%
381
-3
-0.8% -$90
OSIZ
7200
DELISTED
Invesco Russell 1000 Size Factor ETF
OSIZ
$12K ﹤0.01%
400

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.